Exploring Vaccination in Low-Grade Glioma With the Aim of Preventing High-Grade Transformation

May 17, 2017
Hideho Okada, MD, PhD

Hideho Okada, MD, PhD, director, Brain Tumor Immunotherapy Center, professor of Neurological Surgery, University of California, San Francisco, discusses a study exploring vaccination in low-grade glioma aiming at prevention of high-grade transformation.